The combined hepatoprotector Prohepar: experience with clinical use

Gromova O.A.

doi:https://doi.org/

Gromova O.A.

Rossiĭskiĭ satellitnyĭ tsentr instituta mikroélementov IuNESKO;
Laboratoriia vychislitel'noĭ i sistemnoĭ biologii VTs RAN im. A.A. Dorodnitsyna;
kafedra farmakologii i klinicheskoĭ farmakologii Ivanovskoĭ gosudarstvennoĭ meditsinskoĭ akademii

ORCID: 0000-0002-7663-710X

The combined hepatoprotector Prohepar: experience with clinical use

Authors:

Gromova O.A.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2012;15(6): 61‑63

Read: 713 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Gromova OA. The combined hepatoprotector Prohepar: experience with clinical use. Russian Journal of Preventive Medicine. 2012;15(6):61‑63. (In Russ.)

Подписка 2026 Профилактическая медицина (Russian Journal of Preventive Medicine)

Использование инфографики авторами научных работ

References:

Vidal'. Spravochnik "Lekarstvennye preparaty v Rossii". M 2012; 1725.
Toguzov R.T., Gromova O.A., Torshin I.Yu., Grishina T.R., Mamedov E.S., Shachnev E.N. Soderzhanie folatov i lipoevoi kisloty v gepatoprotektore Progepar. Farmateka 2010; 11: 77-82.
Gromova O.A., Torshin I.Yu., Yurgel' I.S., Nazarenko O.A., Grishina T.R., Rudakov K.V. Mekhanizmy deistviya i klinicheskaya effektivnost' kombinirovannogo gepatoprotektornogo preparata Progepar. Trudnyi patsient 2009; 12: 42-47.
Toguzov R.T., Nazarenko O.A., Volkov A.Yu., Torshin I.Yu., Grishina T.R., Shachnev E.N., Gromova O.A. Elementnyi sostav kak odna iz osnov gepatoprotektornogo deistviya preparata "Progepar". Prakticheskaya meditsina 2011; 1: 176-182.
Kim D.S., Kim Y.K., Park H.K., Cho Y.I., Jeong S.K. Serum folate and low-density lipoprotein particle size. J Atheroscler Thromb 2010; 17: 12: 1218-1225.
Smith A.D., Kim Y.I., Refsum H. Is folic acid good for everyone? Am J Clin Nutr 2008; 87: 3: 517-533.
Severin E.S. Biokhimiya M 2008; 967.
Perry M.C., Straker L.M., Oddy W.H. Spinal pain and nutrition in adolescents - an exploratory cross-sectional study. BMC Musculoskelet Disord 2010; 11: 138.
Gropper S., Smith J. Advanced Nutrition and Human Metabolism. 5-th ed. Wadsworth Publishing 2008; 624.
Kenney J.L., Carlberg K.A. The effect of choline and myo-inositol on liver and carcass fat levels in aerobically trained rats. Int J Sports Med 1995; 16: 2: 114-116.
Macfarlane D.P., Zou X., Andrew R., Morton N.M., Livingstone D.E., Aucott R.L., Nyirenda M.J., Iredale J.P., Walker B.R. Metabolic pathways promoting intrahepatic fatty acid accumulation in methionine and choline deficiency: implications for the pathogenesis of steatohepatitis. Am J Physiol Endocrinol Metab 2011; 300: 2: E402-E409.
Steger D.J., Haswell E.S., Miller A.L. Regulation of chromatin remodeling by inositol polyphosphates. Science 2003; 299: 5603: 114-116.
Rukovodstvo po eksperimental'nomu (doklinicheskomu) izucheniyu novykh farmakologicheskikh veshchestv. Pod red. R.U. Khabrieva. M 2005; 832.
Demidov V.I., Nazarenko O.A., Grishina T.R., Torshin I.Yu., Gromova O.A. Effektivnost' primeneniya preparata Progepar pri eksperimental'nom povrezhdenii pecheni alkogolem i paratsetamolom: biokhimiya i gistologiya. Farmateka 2011; 2: 85-90.
Egorova E.Yu., Filosofova M.S., Torshin I.Yu., Yudina N.V., Nazarenko O.A., Yurgel' I.S., Al'per I.A., Grishina T.R., Gromova O.A. Randomizirovannoe kontroliruemoe issledovanie effektivnosti preparata Progepar u patsientov s khronicheskim alkogol'nym gepatitom. Rus med zhurn 2011; 12: 753-764.
Koizumi B., Fukui O. Leberzirrhose und anderen Lebererkrankungen in Japan. Klinische Medizin und Forschung 1972; 49: 261.
Sekiya M., Sugiyama Y., Nishitani Y. Placebo-kontrollierten klinischen Studie der Progeparen bei entzündlichen Erkrankungen der Leber. Leber Galle Bauchspeichedruse 1973; 14: 582.
Fujisawa K., Suzuki H., Yamamoto S., Hirayama C., Shikata T. The therapeutic effects of liver hydrolyzates in chronic hepatitis: a double-blind, controlled study. Asian Med J 1983; 26: 8: 497-526.
Klinicheskaya farmakologiya po Gudmanu i Gilmanu. Pod red. A.G. Gilmana, D. Khardmana, L. Limberda. M 2006; 336.
Normy fiziologicheskikh potrebnostei v energii i pishchevykh veshchestvakh dlya razlichnykh grupp naseleniya Rossiiskoi Federatsii. Metodicheskie rekomendatsii MR 2.3.1.2432-08.
Smit N.P., van der Meulen H., Koerten H.K., Kolb R.M., Mommaas A.M., Lentjes E.G., Pavel S. Melanogenesis in cultured melanocytes can be substantially influenced by L-tyrosine and L-cysteine. J Invest Dermatol 1997; 109: 6: 796-800.
Arrighi F. A valuable treatment of psoriasis (225 patients treated, with 95 percent completely cleared-up in from 4 to 6 weeks). Bull Soc Fr Dermatol Syphiligr 1960; 67: 774-775.
Torshin I.Yu., Gromova O.A. 25 mgnovenii molekulyarnoi farmakologii. M 2012; 560.